{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T11:07:15Z","timestamp":1758280035613},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.jacl.2012.03.002","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T06:15:21Z","timestamp":1332483321000},"page":"443-449","source":"Crossref","is-referenced-by-count":6,"title":["Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia"],"prefix":"10.1016","volume":"6","author":[{"given":"Gregory A.","family":"Nichols","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhakti","family":"Arondekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2012.03.002_bib1","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinternmed.2008.599","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults","volume":"169","author":"Ford","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2012.03.002_bib2","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of high blood cholesterol in adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacl.2012.03.002_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00043798-199604000-00014","article-title":"Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol: a meta-analysis of population-based prospective studies","volume":"3","author":"Hokanson","year":"1996","journal-title":"J Cardiovasc Risk"},{"key":"10.1016\/j.jacl.2012.03.002_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.CIR.85.1.37","article-title":"Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment","volume":"85","author":"Manninen","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2012.03.002_bib5","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2012.03.002_bib6","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 Trial","volume":"51","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2012.03.002_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.amjcard.2009.04.008","article-title":"Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease","volume":"104","author":"Faergeman","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2012.03.002_bib8","unstructured":"National Heart, Lung and Blood Institute. NHLBI Factbook Fiscal Year 2009. 2010. Available at: http:\/\/www.nhlbi.nih.gov\/about\/factbook\/toc.htm. Accessed March 21,\u00a02012."},{"key":"10.1016\/j.jacl.2012.03.002_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.amjcard.2010.09.010","article-title":"Patient characteristics and medical care costs associated with hypertriglyceridemia","volume":"107","author":"Nichols","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2012.03.002_bib10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/intqhc\/10.6.531","article-title":"Building health plan databases to risk-adjust outcomes and payments","volume":"10","author":"Hornbrook","year":"1998","journal-title":"Int J Qual Health Care"},{"key":"10.1016\/j.jacl.2012.03.002_bib11","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1001\/archinte.159.16.1873","article-title":"The progressive cost of complications in type 2 diabetes mellitus","volume":"159","author":"Brown","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2012.03.002_bib12","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular Disease: A scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2012.03.002_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/hec.941","article-title":"Parametric modeling of cost data: some simulation evidence","volume":"14","author":"Briggs","year":"2005","journal-title":"Health Econ"},{"key":"10.1016\/j.jacl.2012.03.002_bib14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.1990.00040031653012","article-title":"Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels","volume":"150","author":"Bookstein","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacl.2012.03.002_bib15","series-title":"USRDS Annual Data Report. Atlas of End-Stage Renal Disease in the United States","year":"2010"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287412000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T01:20:57Z","timestamp":1543108857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287412000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S1933287412000815"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2012.03.002","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}